Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Berger

Showing results (11-20 of 239) with videos related to

Pageof 24
Sort By:
ACP Journal Club|July 2, 2005
A glucose-insulin-potassium infusion did not reduce mortality, cardiac arrest, or cardiogenic shock after acute MIPeter B Berger
The New England Journal of Medicine|March 17, 2010
Optimal duration of clopidogrel use after implantation of drug-eluting stents--still in doubtPeter B Berger
Critical Care Medicine|August 3, 2006
Cardiogenic shock--Beyond the large infarctionGad Cotter, Peter B Berger
Nature Clinical Practice. Cardiovascular Medicine|September 23, 2006
Does clopidogrel pretreatment counteract the benefits of off-pump CABG surgery?Kimberley Skelding, Peter B Berger
Circulation|October 23, 2002
Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspectivePeter B Berger, Steven Steinhubl
Circulation. Cardiovascular Interventions|June 17, 2010
Routine platelet testing should not be performed on all patients undergoing percutaneous coronary interventionArun Kalyanasundaram, Peter B Berger
Journal of Interventional Cardiology|June 11, 2002
The thienopyridinesDieter F Lubbe, Peter B Berger
Current Cardiology Reports|June 9, 2004
Transport and centralization of acute coronary syndrome careJames L Orford, Peter B Berger
ACP Journal Club|November 4, 2006
Review: early statin therapy does not reduce the composite endpoint of death, MI, or stroke in acute coronary syndromesBrian C Carey, Peter B Berger
European Heart Journal|March 19, 2009
Aspirin following PCI: too much of a good thing?Steven R Steinhubl, Peter B Berger
Pageof 24

Showing results (11-20 of 239) with videos related to

Sort By:
Pageof 24
ACP Journal Club|July 2, 2005
A glucose-insulin-potassium infusion did not reduce mortality, cardiac arrest, or cardiogenic shock after acute MIPeter B Berger
The New England Journal of Medicine|March 17, 2010
Optimal duration of clopidogrel use after implantation of drug-eluting stents--still in doubtPeter B Berger
Critical Care Medicine|August 3, 2006
Cardiogenic shock--Beyond the large infarctionGad Cotter, Peter B Berger
Nature Clinical Practice. Cardiovascular Medicine|September 23, 2006
Does clopidogrel pretreatment counteract the benefits of off-pump CABG surgery?Kimberley Skelding, Peter B Berger
Circulation|October 23, 2002
Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspectivePeter B Berger, Steven Steinhubl
Circulation. Cardiovascular Interventions|June 17, 2010
Routine platelet testing should not be performed on all patients undergoing percutaneous coronary interventionArun Kalyanasundaram, Peter B Berger
Journal of Interventional Cardiology|June 11, 2002
The thienopyridinesDieter F Lubbe, Peter B Berger
Current Cardiology Reports|June 9, 2004
Transport and centralization of acute coronary syndrome careJames L Orford, Peter B Berger
ACP Journal Club|November 4, 2006
Review: early statin therapy does not reduce the composite endpoint of death, MI, or stroke in acute coronary syndromesBrian C Carey, Peter B Berger
European Heart Journal|March 19, 2009
Aspirin following PCI: too much of a good thing?Steven R Steinhubl, Peter B Berger
Pageof 24